A9599
Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified
- Release
- October 2026
- Effective
Official Coding Notes
Reproduced verbatim from the October 2026 HCPCS Level II files.
Note
IOM 100-3, CHAPTER 4, 220.6.20.
Version History
How A9599 appears in each release imported from the official files, newest first.
-
October 2026 Effective
InactiveRadiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified
-
July 2026 Effective
InactiveRadiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified
-
April 2026 Effective
InactiveRadiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified
-
January 2026 Effective
InactiveRadiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified
Data Source
Code information on this page is derived from the October 2026 HCPCS Level II files published by CMS.
- Release
- October 2026
- Effective
- Source file
- october-2026-alpha-numeric-hcpcs-file.zip
Official HCPCS Level II source files (opens in a new tab)
MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.
Look up another code
Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.